Home › Breast Cancer › NCT06217874
Collection of Specimens and Clinical Data for Patients With Recurrent or Metastatic Breast Cancer or Male Breast Cancer
RecruitingObservational study
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Female participants must have histologically or cytologically confirmed invasive breast cancer. * Male participants must have biopsy proven breast cancer. * Age must be \>= 18 years, and all must be able to understand and willing to sign an informed consent document. Exclusion Criteria: * Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent; a history of serious or life-threatening allergic reaction to local anesthetics (i.e. lidocaine, xylocaine). * Any other condition, which in the opinion of the patient's treating oncologist, or the physician performing the biopsy procedure, would make participation in this protocol unreasonably hazardous for the patient.
About the study
This study is being done to create a resource of samples and information that can be used to improve our understanding of the development, progression and treatment of recurrent or metastatic breast cancer or male breast cancer.
What is being tested
- Non-Interventional Study (other)
Sponsor: Mayo Clinic · Participants: 2,000 · Started: Jun 5, 2014
Contact the study team
Official record on ClinicalTrials.gov — NCT06217874
Locations in the U.S.
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.